Spouting Rock Asset Management, LLC Penumbra Inc Transaction History

Spouting Rock Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$271.54 - $344.06 $22,266 - $28,212	-82 Reduced 8.1%	930 $319,000
Q1 2023 May 10, 2023	SELL	$220.43 - $278.69 $102,059 - $129,033	-463 Reduced 31.39%	1,012 $282,000
Q4 2022 Feb 13, 2023	SELL	$151.88 - $228.5 $44,956 - $67,636	-296 Reduced 16.71%	1,475 $327,000
Q3 2022 Nov 08, 2022	BUY	$120.36 - $205.88 $15,646 - $26,764	130 Added 7.92%	1,771 $336,000
Q2 2022 Aug 10, 2022	BUY	$116.09 - $227.33 $190,503 - $373,048	1,641 New	1,641 $204,000
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $321,423 - $373,369	-1,282 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$235.0 - $310.7 $23,970 - $31,691	102 Added 8.64%	1,282 $351,000
Q1 2021 May 17, 2021	BUY	$175.6 - $291.43 $207,208 - $343,887	1,180 New	1,180 $319,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.